Journal of Infection in Developing Countries

Papers
(The H4-Index of Journal of Infection in Developing Countries is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
The practice of COVID-19 preventive measures in Palestine on the limits of vaccine provision: a population-based study84
Shifts in hospital-associated pathogens and prevalence trends of carbapenem-resistant Escherichia coli infections, 2021–202330
Use of qRT-PCR for SARS-CoV-2 sgRNA leader for the therapeutic plan: a preliminary report on 10 patients29
Identification of the first case of Penicillium marneffei infection in Shaanxi province by nanopore sequencing27
Mortality predictors on the day of healthcare-associated Acinetobacter baumanni bacteremia in intensive care unit25
Hematological profile among cutaneous leishmaniasis patients before and after treatment with sodium stibogluconate in Diyala, Iraq23
Sequels of COVID-19 in nephrology. Chronic kidney patients are more prone to hemodialysis need and mortality21
SARS-CoV-2 genetic diversity and variants of concern in Saudi Arabia19
The controverted therapeutic efficacy of Allium sativum and Artemisia herba-alba extracts on Cryptosporidium-infected mice19
Successful treatment of peritonitis caused by Acremonium species without catheter removal: Case report and literature review18
Social Network Strategy improves access to HIV testing and harm reduction programs for PWID and their partners in Kazakhstan18
Impact of vaccination on ICU admissions of hospitalized COVID-19 patients in a country with a heterologous vaccine policy18
Real-life outcomes of COVID-19 vaccination in kidney transplant patients: a single-center experience17
Optimized Case Finding of tuberculosis among key populations in Ukraine. A follow up study17
Side effects of COVID-19 vaccines among Iranian healthcare workers: a retrospective cohort study17
A study of anti-SARS-CoV-2 antibody positivity in Duhok City, Iraq16
0.15707898139954